Overexpression of c-Myc inhibits p21(WAF1/CIP1) expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells

Cell Growth and Differentiation

Volumn 10, Issue 4, 1999, Pages 223-230

  Mitchell, Kyran O ^a   El Deiry, Wafik S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P21;

ARTICLE; BREAST CANCER; CELL CYCLE S PHASE; CELL GROWTH; CELL TRANSFORMATION; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; ONCOGENE C MYC; PRIORITY JOURNAL; PROSTATE CANCER;

ADENOVIRIDAE; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; BROMODEOXYURIDINE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KINETICS; LUCIFERASES; MALE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; S PHASE; TETRADECANOYLPHORBOL ACETATE; THYMIDINE; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032920581     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Blackwood, E., and Eisenman, R. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with myc. Science (Washington DC), 251: 1211-1217, 1991.
2. Blackwell, K., Kretzner, L., Blackwood, E., Eisenman, R., and Weintraub, H. Sequence-specific DNA binding by the c-Myc protein. Science (Washington DC), 250: 1149-1151, 1990.
3. Kato, G., Barrett, J., Villa-Garcia, M., and Dang, C. An amino-terminal c-Myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol., 10: 5914-5920, 1990.
4. Li, L., Nerlov, C., Prendergast, G., MacGregor, D., and Ziff, E. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J., 13: 4070-4079, 1994.
5. Rosenwald, I., Rhoads, D., Callanan, L., Isselbacher, K., and Schmidt, E. Increased expression of eukaryotic translation initiation factors elF-4E and elf-2 α in response to growth induction by c-Myc. Proc. Natl. Acad. Sci. USA, 90: 6175-6178, 1993.
6. 1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol. Cell. Biol., 15: 2527-2535, 1995.
7. Eilers, M., Schrim, S., and Bishop, J. The MYC protein activates transcription of the α-prothymosin gene. EMBO J., 10: 133-141, 1991.
8. Wagner, A., Meyers, C., Laimins, L., and Hay, N. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ., 4: 879-883, 1993.
9. Grandori, C., Mac, J., Siebelt, F., Ayer, D., and Eisenman, R. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J., 75: 4344-4357, 1996.
10. Benvensity, N., Leder, A., Kuo, A., and Leder, P. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev., 6: 2513-2523, 1992.
11. Galaktionov, K., Chen, X., and Beach, D. Cdc25A cell-cycle phosphatase as a target of c-Myc. Nature (Lond.), 382: 511-517, 1996.
12. Antonson, P., Pray, M. G., Jacobsson, A., and Xanthopoulos, K. G. Myc inhibits CCAAT/enhancer-binding protein α-gene expression in HIB-1B hibemoma cells through interactions with the core promoter region. Eur. J. Biochem., 232: 397-403, 1995.
13. Philipp, A., Schneider, A., Vasrik, I., Finke, K., Xiong, Y., Beach, D., Alitalo, K., and Eilers, M. Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol., 14: 4032-4043, 1994.
14. Tikhonenko, A. T., Black, D. J., and Linial, M. L. Viral myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene. J. Biol. Chem., 271: 30741-30747, 1996.
15. Marhin, W. W., Chen, S., Facchini, L. M., Fornace, A. J., Jr., and Penn, L. Z. Myc represses the growth arrest gene gadd45. Oncogene, 14: 2825-2834, 1997.
16. WAF1/CIP1, Rb, and c-Myc signaling in phorbol ester-resistant cancer cells. Cancer Res., 57: 320-325, 1997.
17. 1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
18. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369: 574-578, 1994.
19. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-Myc protein. Cell, 69: 119-128, 1992.
20. WAF1/CIP1 expression inhuman breast carcinoma cells. Cancer Res., 56: 5055-5062, 1996.
21. WAF1/CIP1 expression by p53-independent pathways. Oncogene, 12: 1557-1564, 1996.
22. El-Deiry, W. S. p21/p53, cellular growth control, and genomic integrity. Curr. Topics Microbiol. Immunol., 227; 121-137, 1998.
23. WAF1/CIP1 arrests the growth of chicken embryo fibroblasts transformed by individual oncogenes. Oncogene, 11: 2609-2618, 1995.
24. CIP1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev., 10: 3065-3075, 1996.
25. Somasundaram, K., and El-Deiry, W. S. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene, 14: 1047-1057, 1997.
26. Wang, X. W., and Walsh, K. Resistance to apoptosis conferred by cdk inhibitors during myocyte differentiation. Science (Washington DC), 273: 359-361, 1996.
27. WAF1/CIP1 against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol. Cell. Biol., 16: 6654-6660, 1996.
28. Waldman, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (Lond.), 387: 713-716, 1996.
29. Leone, G., DeGregori, J., Sears, R., Jakoi, L., and Nevins, J. R. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature (Lond.), 387: 422-426, 1997.
30. de Cremoux, P., Gauville, C., Closson, V., Linares, G., Calvo, F., Tavitian, A., and Olofsson, B. EGF modulation of the ras-related rhoB gene expression in human breast cancer cell lines. Int. J. Cancer, 59: 408-415, 1994.
31. Clark, J. W., Santos-Moore, A., Stevenson, L. E., and Frackelton, A. R., Jr. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway. Int. J. Cancer, 65: 186-191, 1996.
32. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
33. WAF1/CIP1 deficient in PCNA interaction. Clin. Cancer Res., 2: 1221-1229, 1996.
34. Blagosklonny, M. V., and El-Deiry, W. S. In vitro evaluation of a p53-expressing adenovirus as an anticancer drug. Int. J. Cancer, 67: 386-392, 1996.
35. Zeng, Y-X., Somasundaram, K., Prabhu, N. S., Krishnadasan, R., and El-Deiry, W. S. Detection and analysis of living, growth-inhibited mammalian cells following transfection. Biotechniques, 23: 88-94, 1997.
36. WAF1/CIP1 expression. Nat. Genet., 15: 78-82, 1997.